Vancouver, Canada

Nikolay Mintchev Stoynov

This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Panion & Bf Biotech Inc.. Active years: 2010-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikolay Mintchev Stoynov. Retrieved from https://idiyas.com/inventor/nikolay-mintchev-stoynov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 80.0


 

Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Nikolay Mintchev Stoynov

Introduction

Nikolay Mintchev Stoynov is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on ferric organic compounds. With a total of 10 patents to his name, Stoynov's inventions are paving the way for advancements in medical treatments.

Latest Patents

Stoynov's latest patents include groundbreaking developments in ferric organic compounds. One notable invention is titled "Ferric organic compounds, uses thereof and methods of making same." This patent discloses a novel form of ferric organic compounds, including ferric citrate, which are soluble over a wider range of pH and possess a large active surface area. These compounds can be effectively delivered orally, providing better treatment options for patients suffering from hyperphosphatemia, metabolic acidosis, and other disorders responsive to ferric organic compound therapy. Another significant patent is "Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same." This invention outlines pharmaceutical-grade ferric organic compounds, including ferric citrate, and details a manufacturing and quality control process that ensures compliance with established specifications. These compounds are particularly suitable for treating disorders characterized by elevated serum phosphate levels.

Career Highlights

Throughout his career, Stoynov has worked with notable companies such as Panion & Bf

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…